Hypolipidemic Therapy and Chronic Kidney Disease: Effects on Cardiovascular Risks and Renal Dysfunction

Айтбаев, К А; Муркамилов, И Т; Фомин, В В

doi:10.18087/cardio.2019.2.10231

Cited by 4 publications

(3 citation statements)

References 72 publications

(54 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…As the global population ages at an unprecedented rate, the incidence of chronic diseases is soaring, and chronic kidney disease (CKD) is no exception ( 1 ). The more patients suffer from CKD, the more develop end-stage renal disease (ESRD) ( 2 ). ESRD is diagnosed when kidney function is insufficient to sustain life without kidney transplantation or dialysis ( 3 ), and its prevalence is also rising ( 4 ).…”

Section: Introductionmentioning

confidence: 99%

Mobile health management among end stage renal disease patients: a scoping review

Wen,

Ruan,

2024

Front. Med.

View full text Add to dashboard Cite

AimsThe health management of end-stage renal disease patients is a complicated process, and mobile health management technology provides a new choice for the health management of end-stage renal disease patients. The scope of clinical studies on mobile health management for patients with end-stage renal disease was reviewed, and found that about mobile health management problems existing in the literature were identified to provide ideas for subsequent mobile health management research.MethodsThe databases Web of Science, PubMed, The Cochrane Library, Embase, CNKI, Wan Fang Data, BMJ, and VIP were systematically searched for studies on Mobile health management among end-stage renal disease in adult and adolescent patients or children undergoing kidney replacement therapy. The search covered the period from the inception of the databases to June 20, 2023. Two independent reviewers conducted the literature screening process. Following eligibility screening, a total of 38 papers were included for data extraction and descriptive analysis.ResultsA total of 38 studies from 14 countries were finally included. The majority of which were interventional trials. The platforms used in these studies included remote monitoring systems, apps, websites, mobile phones or tablets, and social platforms. These platforms provided patients with a wide range of services, including disease management, behavioral intervention, social support, and follow-up care. Most studies focused on patient clinical indicators, patient experience, quality of life, and healthcare costs.ConclusionOur findings that mobile health management has been widely used in disease management of end-stage renal disease patients, with rich management content and many evaluation indicators. Future studies should strengthen the evaluation of patients’ mental health, quality of life, and healthcare costs. Additionally, developing a clinical decision support system would enable mobile health management to play a more effective role in end-stage renal disease patients.

show abstract

Section: Introductionmentioning

confidence: 99%

Mobile health management among end stage renal disease patients: a scoping review

Wen,

Ruan,

2024

Front. Med.

View full text Add to dashboard Cite

show abstract

“…Dyslipidemia is defined as the imbalance of cholesterol, low-density lipoprotein cholesterol, triglycerides, and high-density lipoprotein. It is seen as a key risk factor in the formation and development of cardiovascular disease, stroke heart failure, and renal failure [ 2 , 3 ]. A national survey showed that the overall prevalence of dyslipidemia among Chinese adults is steadily rising [ 4 , 5 ].…”

Section: Introductionmentioning

confidence: 99%

The Effect of Psychological Burden on Dyslipidemia Moderated by Greenness: A Nationwide Study from China

Liu

et al. 2022

IJERPH

View full text Add to dashboard Cite

Globally, dyslipidemia is now become a leading risk factor for many adverse health outcomes, especially in the middle-aged and elderly. Recent evidence suggests that exposure to greenness and the relief of a psychological burden may decrease the prevalence of dyslipidemia. The objective of our study was to examine whether a green space can moderate the association between mental health status and dyslipidemia. Our study selected the datasets of depression symptoms, dyslipidemia from the China Health and Retirement Longitudinal Study (CHARLS), and the satellite-based normalized difference vegetation index (NDVI) from the 30 m annual maximum NDVI dataset in China in 2018. Ultimately, a total of 10,022 middle-aged and elderly Chinese were involved in our study. Multilevel logistic regressions were performed to examine the association between symptoms of depression and dyslipidemia, as well as the moderate effect of greenness exposure on the association. Our research suggested that adults diagnosed with depression symptoms were more likely to suffer from dyslipidemia. In addition, the NDVI was shown to moderate the effect of depression on dyslipidemia significantly, though the effect was attenuated as depression increased. Regarding the moderate effect of the NDVI on the above association across age, gender, and residence, the findings presented that females, the elderly, and respondents living in urban areas were at a greater risk of having dyslipidemia, although the protective effect of the NDVI was considered. Likewise, the moderate effect of the NDVI gradually decreased as the level of depression increased in different groups. The current study conducted in China provides insights into the association between mental health, green space, and dyslipidemia. Hence, improving mental health and green spaces can be potential targets for medical interventions to decrease the prevalence of dyslipidemia.

show abstract

“…Chronic kidney disease is an important public health problem (1), with 8-10% of the adult population having some form of kidney damage (2). According to the Turkish Society of Nephrology Registry Report, end-stage renal disease (ESRD) prevalence is 957 per million population in Turkey in 2017 (3).…”

Section: Introductionmentioning

confidence: 99%

Validity and Reliability of a Turkish Version of the Relationship and Sexuality Scale for Kidney Transplant Recipients

Akkoç¹,

Aksoy²

2021

Akdeniz Medical Journal

View full text Add to dashboard Cite

Objective: The aim of this study was to evaluate the validity and reliability of Relationship and Sexuality Scale for kidney transplant recipients in Turkey. Material and Methods: This methodological study was conducted with 150 kidney transplant recipients applied to transplant center of a university hospital between November 2016 and February 2017. "Patient Identification Form", "Relationship and Sexuality Scale" and "The Arizona Sexual Experiences Scale" were used as data collection instruments. The data were analyzed on SPSS 23 through numbers, percentage, mean, standard deviation, content validity index, factor analysis, correlation analysis and coefficient alpha. The validity of the scale was tested using the content validity index and confirmatory and exploratory factor analyses. The process of adaptation and translation of instruments by World Health Organization was followed to provide language validity. Expert opinion was received for content validity and it was found to be coherent. The questionnaire's factor structure demonstrated good fit, implying that it could be applied to the Turkish kidney transplant recipients population. Results: The scale consisted of three sub-dimensions according to validity testing. None of the original items were excluded. The general cronbach's alpha coefficient of the scale was found 0.84. The principal components analysis revealed 3 factors explaining 66.40% of the variance. Correlations between item-total correlation and sub-dimensions were found positive, medium-level and statistically significant (p<0.01). Conclusion: Content validity, construct validity, and reliability analyses of the Relationship and Sexuality Scale revealed that the scale may be used to measure relationships and sexuality of kidney transplant recipients in Turkey.

show abstract

Hypolipidemic Therapy and Chronic Kidney Disease: Effects on Cardiovascular Risks and Renal Dysfunction

Cited by 4 publications

References 72 publications

Mobile health management among end stage renal disease patients: a scoping review

Mobile health management among end stage renal disease patients: a scoping review

The Effect of Psychological Burden on Dyslipidemia Moderated by Greenness: A Nationwide Study from China

Validity and Reliability of a Turkish Version of the Relationship and Sexuality Scale for Kidney Transplant Recipients

Contact Info

Product

Resources

About